Furthermore, the CD94/NKG2C receptors in CeD patients are associated with the ITAM-bearing adaptor molecule DAP12, enabling cytokine secretion, proliferation and cytolytic activity in response to NK receptor ligands, even independently of TCR activation (79). This evidence concerns the gene KLRD1 and cranioectodermal dysplasia.